Observing vulvar diseases in Nigeria
Vulvar Disease in Nigeria - Registry ( Observationsl Study)
This study looks at how much people in Nigeria know about vulvar diseases and how common these conditions really are in different communities.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 10 Years to 90 Years |
| Sex | Female |
| Sponsor | KDRS ltd Industry-sponsored |
| Locations | 1 site (London) |
| Trial ID | NCT05890092 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on understanding the awareness and prevalence of vulvar diseases among patients and health practitioners in Nigeria. It aims to gather self-reported data and compare it with actual prevalence rates within various communities. By observing these factors, the study seeks to highlight gaps in knowledge and care regarding vulvar health. The methodology involves collecting data through surveys and community outreach.
Who should consider this trial
Good fit: Ideal candidates for this study are biological females residing in Nigeria.
Not a fit: Patients who are not biological females will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance awareness and improve healthcare practices related to vulvar diseases in Nigeria.
How similar studies have performed: While there may be limited studies specifically focused on vulvar diseases in Nigeria, observational studies in similar contexts have shown success in raising awareness and improving health outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * biological females - afab Exclusion Criteria: * none-afab
Where this trial is running
London
- Kdrs — London, United Kingdom (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.